Minchao Kang

机构：Sir Run Run Shaw Hospital, Hangzhou Xixi hospital, Zhejiang University

发表论文 11 篇 · 总被引 87 次 · h-index 4

代表论文

• Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway (2023 · Phytomedicine · 被引 40)
• The Arachidonic Acid Metabolism Mechanism Based on UPLC-MS/MS Metabolomics in Recurrent Spontaneous Abortion Rats (2021 · Frontiers in Endocrinology · 被引 31)
• Anti–Na+/K+-ATPase DR antibody attenuates UUO-induced renal fibrosis through inhibition of Na+/K+-ATPase α1–dependent HMGB1 release (2023 · International Immunopharmacology · 被引 7)
• Na + /K + -ATPase DR region antibody ameliorated cardiac hypertrophy and fibrosis in rats with 5/6 nephrectomy (2022 · Experimental Biology and Medicine · 被引 5)
• Single cell analysis identified IFN signaling activation contributes to the pathogenesis of pediatric steroid-sensitive nephrotic syndrome (2025 · Biomarker Research · 被引 2)
• Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis (2025 · Journal of the American Society of Nephrology · 被引 1)